The agreement ties in with Lilly's strategy of making genetic medicines targeting DNA and RNA a key pillar of its R&D, ...

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an ...

The CEO's departure comes after Lykos co-founder and longtime psychedelic medicines advocate Rick Doblin stood down from the ...

J&J has taken all its talc-based products off the market as of 2023 and is now using cornstarch instead. In its ...

The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance ...

Pay a tax of up to 1,900% (not 95%) on the total sales revenue of the medicine selected for price setting. News coverage ...

The company recently claimed FDA approval for the first description DTx for major depressive disorder (MDD) – ...

Now, in a stunning reversal, Advanz has won a reprieve after the General Court of the European Union ordered a suspension of ...

Swiss startup Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies ...

Medscape Medical Affairs operates across every phase of the medical discovery and development process, ensuring that the ...

Along with its in-house programmes, ArsenalBio has attracted some big-name pharma partners, including Bristol-Myers Squibb – ...

The European Commission has followed the advice of its human medicines committee and revoked the conditional marketing ...